US 8569351
Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
granted A61KA61K31/415A61K31/4164
Quick answer
US patent 8569351 (Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity) held by Theravance, Inc. expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/415, A61K31/4164, A61K31/417, A61K31/4188